 Home > Active Ingredient News > Infection > Briefing on October 13, 2021: The new crown vaccine can reduce the risk of hospitalization by 90%; the Chinese vaccine will be approved by the EU at the end of the year as soon as possible!

Briefing on October 13, 2021: The new crown vaccine can reduce the risk of hospitalization by 90%; the Chinese vaccine will be approved by the EU at the end of the year as soon as possible!

 Last Update: 2021-10-19
 Source: Internet
 Author: User

Tags

12 september 2019

80 20 distributors

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

As of 7:01 Beijing time on October 13, 2021, Worldometers world real-time statistics show that the cumulative number of confirmed new coronary pneumonia ( COVID-19 ) cases worldwide has exceeded 239.
39 million, with an increase of 356,863 cases, reaching 239,399,191
.

The total number of deaths was 4.

New Coronary Pneumonia COVID-19 Briefing on October 12, 2021: After inactivated vaccination and boosted vaccination with mRNA vaccine, the neutralizing antibody increased by 46.

More than 10 provinces across the country to fight vaccine booster immunization vaccination

More than 10 provinces across the country to fight vaccine booster immunization vaccination immunity

In September this year, Zhejiang, Henan and other places proposed to start the new coronavirus vaccine booster immunization work
.

Up to now, according to incomplete statistics, more than 10 provinces, including Anhui, Fujian, Henan, Heilongjiang, and Hubei, have clearly initiated intensified vaccination

U.
S.
FDA experts say two doses of new crown vaccine are sufficient to prevent severe illness and death

US FDA experts said the two new crown vaccine sufficient to prevent severe and fatal US FDA experts said the two new crown vaccine sufficient to prevent severe and fatal FDA prevention

On Tuesday, the US Food and Drug Administration Administration (FDA) declined to comment on whether to approve Moderna (MRNA.
US) new crown vaccine booster vaccination expression position
.

Scientists from the bureau said that data show that two doses of vaccine are still sufficient to prevent severe illness and death in the United States

manage

A document published on the FDA website stated: “Some effectiveness studies on actual conditions indicate that over time, the effectiveness of Moderna vaccine against asymptomatic infections or against delta variants is declining, while others The research by the
United States did not show such a conclusion .

However, overall, the data shows that the new coronavirus vaccine currently licensed or authorized in the United States can still prevent severe illness and death in the United States

Infect

FDA staff also did not comment on Pfizer (PFE.
US)'s new crown vaccine booster last month
.

But this did not prevent the agency’s vaccine and related biological products advisory committee from recommending a third injection

The committee rejected Pfizer’s original plan to vaccinate all people 16 years and older with booster shots, narrowing the scope of vaccination to those at the highest risk of new crown infection, including the elderly and people with other health problems
.

FDA officials later expanded the eligible population to include those who work or live in high-risk environments, such as health care and grocery store workers

This report by FDA scientists is intended to report to the committee
.

The committee will meet on Thursday to consider Moderna’s request for a vaccine booster

On September 1, Moderna applied to the FDA for authorization of enhanced needles
.

The company stated that the dose of the third injection is only half the dose of the first two injections, which is safe, and the immune response produced is stronger than that after the second injection in the third phase of clinical trials
.

As of last Saturday, October 9, more than 7 million Americans had been vaccinated with the new crown vaccine booster
.
FDA and CDC officials once believed that if only Pfizer vaccine booster is approved, tens of millions of Americans who have been vaccinated with Moderna or Johnson & Johnson will be excluded from stronger protection
.

The new crown vaccine can reduce the risk of hospitalization by 90%

The new crown vaccine can reduce the risk of hospitalization ninety new crown vaccine can reduce the risk of hospitalization ninety percent

Researchers from Epi-Phare, a scientific research team composed of the French Medical Insurance Agency and the French National Agency for Drug Safety, compared approximately 11 million French vaccinators over the age of 50 from December 27, 2020 to July 20, 2021.
And the data of about 11 million people of the same age who have not been vaccinated against the new crown
.
The results showed that from the 14th day after the second dose of the new crown vaccine, the risk of hospitalization and death of the vaccinated person was reduced by 90%, and this effect did not decrease in the following five months
.
These data are consistent with the research results of other countries such as Israel, the United Kingdom, and the United States
.

The head of the research team and epidemiologist Mahmoud Zurek said that this is the largest study of the effectiveness of the new crown vaccine in the world so far
.
The results of the study mean that the risk of vaccinated people being hospitalized or dying due to new crown infection is only one-ninth of those who have not been vaccinated
.

On the other hand, the new crown vaccine seems to be equally effective against the "Delta" variant.
During the period when the "Delta" variant is dominant in France, the relevant data is close to the previous data: the effectiveness for the age group of 75 years and older is 84 %, the effectiveness of the 50-74-year-old age group is more than 92%
.
However, Zurek said that because the research time is very short, it is impossible to accurately assess the actual protective effect of the new crown vaccine against the "delta" variant, so this research will continue
.

China's vaccine will be approved by the European Union at the end of the year as soon as possible!

The European Medicines Agency is expected to decide before the end of the year whether to approve four more new coronavirus vaccines-including vaccines made in China and Russia.
Cavalelli, the agency’s vaccine strategy director, said that communication with Chinese and Russian vaccine manufacturers is "Constructive", but more data is needed
.

The British government currently recognizes two doses of vaccines in Europe and the United States, that is, the vaccines approved by the US Food and Drug Administration and the European Medicines Agency
.

This means that once the EU approves, the Chinese vaccine will also be recognized by the United Kingdom.
If according to British media reports, the United Kingdom will cancel the list of countries with amber and green lights next month, and use the status of vaccination to determine whether immigrants should be quarantined or tested.
Mainland China will be vaccinated.
After the two doses of Chinese vaccines are approved by the UK, they will be exempted from isolation or even testing after entering the UK
.

"The Times" reported that as part of the UK's new entry policy, the British government plans to consider removing the requirement to test incoming passengers with two doses of vaccines (a type recognized by the UK), except for those from red countries
.
The official website of the Schengen visa shows that at present, some EU/Schengen countries recognize Chinese vaccines as proof of entry immunization
.

Which recognized China National Pharmaceutical vaccine are: Austria, Cyprus, Greece, Hungary, Iceland, the Netherlands, Spain, Sweden, Finland, Switzerland, Serbia, Montenegro, Macedonia, North and other
.

Austria, Cyprus, Greece, Hungary, Iceland, Netherlands, Spain, Sweden, Finland, Switzerland, Serbia, Montenegro, North Macedonia

Approved Sinovac vaccine are: Austria, Cyprus, Finland, Greece, Iceland, the Netherlands, Spain, Sweden, Switzerland, Serbia, Albania, Macedonia, North and other
.

Austria, Cyprus, Finland, Greece, Iceland, Netherlands, Spain, Sweden, Switzerland, Serbia, Albania, North Macedonia

Ireland, decided to fully liberalize from October 22

Ireland recently announced that it will be fully liberalized from October 22
.
The specific plan to relax the restrictions lasts from September to October, including allowing the restoration of the Holy Communion and the Belief.
The bingo hall, bowling alley, indoor sports, dance and other courses will return on September 20, and the nightclub will also reopen.

.

Ireland was once one of the countries with the longest lockdown period in Europe, and is now one of the most successful countries in Europe to implement COVID-19 vaccination, with a total proportion of 70%
.
Among them, the adult vaccination rate is more than 90%, and the vaccination rate for people over 12 years old is more than 80%
.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.